Mar 3, 2026 05:31PM
Dec 16, 2025 06:07AM
Nov 10, 2025 04:15PM
Nov 6, 2025 11:00AM
Nov 6, 2025 11:00AM
Aug 12, 2025 04:01PM
Jul 15, 2025 07:30AM ProKidney secures FDA alignment on accelerated approval pathway for rilparencel
Jul 15, 2025 07:30AM
Jul 15, 2025 06:23AM
Jul 14, 2025 07:55AM
Jul 9, 2025 07:30AM
Jul 8, 2025 04:49PM
Jul 8, 2025 07:00AM
Jul 8, 2025 07:00AM ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
Jul 1, 2025 12:44PM
Jul 1, 2025 12:43PM
May 12, 2025 04:15PM
Mar 17, 2025 07:30AM
Jan 7, 2025 07:30AM
Nov 26, 2024 07:30AM
Nov 12, 2024 07:30AM ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
Nov 5, 2024 07:30AM
Oct 14, 2024 07:30AM
Oct 9, 2024 07:30AM
Sep 3, 2024 04:49PM
Sep 3, 2024 07:31AM
Sep 3, 2024 07:30AM
Aug 27, 2024 07:30AM ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Aug 9, 2024 07:00AM
Jun 17, 2024 07:00AM
Jun 12, 2024 05:48AM
Jun 11, 2024 09:35PM
Jun 10, 2024 04:15PM
Jun 10, 2024 04:15PM
Jun 10, 2024 06:30AM ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
Jun 10, 2024 05:30AM
May 29, 2024 07:00AM
May 21, 2024 07:00AM
May 10, 2024 07:00AM
Mar 25, 2024 06:06AM
Mar 25, 2024 06:05AM
Mar 21, 2024 07:49PM ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Feb 29, 2024 04:05PM
Nov 30, 2023 06:05AM
Nov 21, 2023 06:05AM
Nov 14, 2023 06:05AM
Nov 13, 2023 05:02PM
Nov 13, 2023 05:02PM
Oct 30, 2023 04:12PM ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
Sep 5, 2023 06:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All